Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.

Baumert T, Urbanek-Quaing M, Cornberg M.

DOI: 10.1136/gutjnl-2024-332679
Published: 2024-11-11
Container: Gut
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/gutjnl-2024-332679,
  title = {Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.},
  author = {Baumert T and  Urbanek-Quaing M and  Cornberg M.},
  year = {2024},
  journal = {Gut},
  doi = {10.1136/gutjnl-2024-332679},
  url = {https://doi.org/10.1136/gutjnl-2024-332679}
}

RIS

TY  - JOUR
TI  - Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.
AU  - Baumert T
AU  -  Urbanek-Quaing M
AU  -  Cornberg M.
PY  - 2024
JO  - Gut
DO  - 10.1136/gutjnl-2024-332679
UR  - https://doi.org/10.1136/gutjnl-2024-332679
ER  -

APA

T, B., M, U., & M., C. (2024). Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.. Gut. https://doi.org/10.1136/gutjnl-2024-332679

Source records

europe-pmc · retrieved 2026-09-27T06:00:43.199Z
hal · retrieved 2026-09-27T06:00:43.236Z